by admin | Jul 12, 2024 | News & Opinions
By Baylor College of Medicine – Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using...
by admin | Jul 11, 2024 | News & Opinions
By Gabrielle Masson – Fierce Biothech – J.P. Morgan Private Capital has closed an inaugural life sciences fund of more than $500 million, cash that will go toward a wide range of private biotechs and build value for existing portfolio companies. Dubbed the...
by admin | Jul 10, 2024 | News & Opinions
By Karlsruhe Institute of Technology – KIT Researchers and Industry Partners Develop Process for Printing Personalized Corneas; Project Wins NEULAND Innovation Contest Printing a new cornea during an operation to restore a patient’s eyesight: This groundbreaking...
by admin | Jul 9, 2024 | News & Opinions
by Jackson Laboratory – Medical Express – Our bone marrow—the fatty, jelly-like substance inside our bones—is an unseen powerhouse quietly producing 500 billion new blood cells every day. That process is driven by hematopoietic stem cells that generate all...
by admin | Jul 8, 2024 | News & Opinions
By PubMed – The analysis on phase 1/2a trial which had several modifications in protocol is currently ongoing. Despite several limitations that need to be overcome, stem cell therapy could be a potential therapeutic option for treating IC/BPS. Clinical outcome...
by admin | Jul 5, 2024 | News & Opinions
By Genetic Engineering and Biotechnology News – Stem cell research recently celebrated its 60th anniversary. Although the first publications in this field appeared in the early 1960s, it took another 20 years before the first embryonic stem cells could be...
